Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 5, 2021

Study Completion Date

June 5, 2021

Conditions
Anemia of End Stage Renal Disease
Interventions
OTHER

Specimen collection

At the beginning of each midweek hemodialysis session, a blood specimen (4 mL) will be drawn from the study subject. Out of this specimen a 1 mL serum sample will be frozen and stored. A 3 mL blood sample will be shipped overnight to WNERTA for laboratory testing.

Trial Locations (3)

27710

Duke University, Durham

40202

University of Louisville, University Kidney Center, Louisville

01107

Western New England Renal and Transplant Associates, Springfield

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Louisville

OTHER

NCT01719146 - Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease | Biotech Hunter | Biotech Hunter